Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, liquid-phase peptide synthesis, solid-state science, material characterization, and highly potent APIs.
Looking for a particular Cambrex employee's phone or email?
The Cambrex annual revenue was $717.6 million in 2026.
Thomas Loewald is the CEO of Cambrex.
1,082 people are employed at Cambrex.
Cambrex is based in East Rutherford, New Jersey.
The NAICS codes for Cambrex are [3254, 32, 32541, 325].
The SIC codes for Cambrex are [2834, 28, 283].